MAGENE TEAMS UP WITH US FIRM TO TAP EU & US BIO-GENERICS MARKET
Magene Life Sciences Private Ltd is taking up bio-therapeutic development activity for a US company, which has its subsidiary in Hyderabad. The company will be delivering the recombinant therapeutic protein starting from cloning through all the stages upto pre-clinical validation in animals. The company intends to develop a formulation, which will be non-infringing in global markets. Magene and its US collaborator plan to target bio-generics markets of US and the Europe.